Anemia in Patients With a Non-Myeloid Malignancy

NCT00038064 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

707

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms
Anemia

Interventions

DRUG: Darbepoetin alfa
DRUG: rHuEPO

Sponsor

Amgen